Abstract
The growing number of drug-resistant bacterial infections worldwide is driving renewed interest in phage therapy. Based on the use of a personalized cocktail composed of highly specific bacterial viruses, this therapy relies on a range of tests on agar media to determine the most active phage on a given bacterial target (phage susceptibility testing), or to isolate new lytic phages from an environmental sample (enrichment of phage banks). However, these culture-based techniques are still solely interpreted through direct visual detection of plaques. The main objective of this work is to investigate computer-assisted methods in order to ease and accelerate diagnosis in phage therapy but also to study phage plaque growth kinetics. For this purpose, we designed a custom wide-field lensless imaging device, which allows continuous monitoring over a very large area sensor (3.3 cm2). Here we report bacterial susceptibility to Staphylococcus aureus phage in 3 hr and estimation of infectious titer in 8 hr 20 min. These are much shorter time-to-results than the 12 to 24 hours traditionally needed, since naked eye observation and counting of phage plaques is still the most widely used technique for susceptibility testing prior to phage therapy. Moreover, the continuous monitoring of the samples enables the study of plaque growth kinetics, which enables a deeper understanding of the interaction between phage and bacteria. Finally, thanks to the 4.3 μm resolution, we detect phage-resistant bacterial microcolonies of Klebsiella pneumoniae inside the boundaries of phage plaques and thus show that our prototype is also a suitable device to track phage resistance. Lensless imaging is therefore an all-in-one method that could easily be implemented in cost-effective and compact devices in phage laboratories to help with phage therapy diagnosis.
Highlights
The increasing number of drug-resistant bacterial infections is an emerging global health crisis that is driving a growing demand for phage therapy [1]
First implemented in 1919 [2], phage therapy is based on the use of highly specific bacterial viruses called bacteriophages or phages
In recent years, promising clinical studies of phage therapy were conducted to treat infection of burn wounds [3], urinary tract infections [4], and chronic otitis [5] caused by antibiotic-resistant bacteria
Summary
The increasing number of drug-resistant bacterial infections is an emerging global health crisis that is driving a growing demand for phage therapy [1]. Regarding the high specificity of phages to particular bacterial species and even particular strains thereof, phage therapy is envisioned as part of a shift to a new paradigm of personalized medicine wherein personalized phage cocktails are administered combining only the most effective phages for a given bacterial isolate [8]. This approach requires access to large phage libraries (or phage banks) that must be maintained and constantly replenished with novel lytic phages targeting otherwise phage-resistant clones. The success of personalized phage medicine largely relies on our capacity to quickly identify and isolate new lytic phages against a diverse range of pathogens [10] as well as to monitor the development of phage-resistance
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have